StockNYSE · US · USDCommunication Services · Telecom Services
$TU
TELUS CORP
TELUS is a telecommunications and technology company headquartered in Vancouver, British Columbia. Its TELUS technology solutions business provides mobile wireless, internet, security, television, voice and IoT connectivity services, as well as health and agriculture and consumer goods solutions. TELUS Health offers virtual care, pharmacy, employee assistance, health benefits, well-being and retirement services. TELUS Digital provides digital customer experience services, consulting and software development, including AI solutions for clients. TELUS makes money by providing connectivity and technology services to consumers, businesses and organizations, including mobile and fixed data subscriptions, health services and digital experience services. Its offerings include TELUS PureFibre, SmartHome+, TELUS Health MyCare, TELUS Agriculture solutions and TELUS Digital’s Fuel iX platform.
Grey Matters Health completed Medicare/Medicaid enrollment for a Florida clinic. Intel shares fell 6% amid a shareholder lawsuit. Telus shares rose 11% on a $21.7B takeover offer. Summit Therapeutics shares dropped 12.69% after FDA rejection. Ceres Power shares rose 8% on a new manufacturing deal.
BMO downgraded Quebecor from outperform to market perform, citing regulatory and transaction risks from its C$31 billion offer to buy Telus. The analyst noted the deal replaces Quebecor's previous growth strategy, raising concerns about execution and regulatory hurdles.
CG Oncology (CGON) rose 12.36% to $83.59, H World (HTHT) +10.24% to $55.55, Telus (TU) +9.62% to $9.35, Molina (MOH) +9.16% to $228.68, Powell (POWL) +7.12% to $152.88. Summit (SMMT) fell 15.51% to $11.96, Gunnison (GUNN) -14.41% to $6.59, GDS (GDS) -13.76% to $17.09, RUM (RUM) -12.91% to $5.03, Strive (ASST) -10.44% to $19.13.
via TradingView
TU sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 15 news stories mentioning TU (TELUS CORP). Coverage has skewed bullish: 6 bullish, 5 neutral, and 4 bearish.
Recent TU coverage spans market movers, financial news and earnings.
What's driving TU
M&A bid support should lift the stock, with focus shifting to deal terms, approvals, and potential competing bids.
Telus Corp. (T-T) has withdrawn from two planned AI data centres in Vancouver due to local opposition and strategic shifts. The company had planned to equip the centres with 63,000 Nvidia (NVDA-Q) chips and draw 163 megawatts of electricity. Westbank Corp. will continue the projects with a new partner. Telus remains open to future opportunities at these sites and will expand its facility in Kamloops, B.C.
AlphAI scores every news story that mentions TU with an AI model for sentiment and relevance, and aggregates insider trades from TELUS CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Grey Matters Health completed Medicare/Medicaid enrollment for a Florida clinic. Intel shares fell 6% amid a shareholder lawsuit. Telus shares rose 11% on a $21.7B takeover offer. Summit Therapeutics shares dropped 12.69% after FDA rejection. Ceres Power shares rose 8% on a new manufacturing deal.
BMO downgraded Quebecor from outperform to market perform, citing regulatory and transaction risks from its C$31 billion offer to buy Telus. The analyst noted the deal replaces Quebecor's previous growth strategy, raising concerns about execution and regulatory hurdles.
CG Oncology (CGON) rose 12.36% to $83.59, H World (HTHT) +10.24% to $55.55, Telus (TU) +9.62% to $9.35, Molina (MOH) +9.16% to $228.68, Powell (POWL) +7.12% to $152.88. Summit (SMMT) fell 15.51% to $11.96, Gunnison (GUNN) -14.41% to $6.59, GDS (GDS) -13.76% to $17.09, RUM (RUM) -12.91% to $5.03, Strive (ASST) -10.44% to $19.13.
Telus Corp's stock surged 25.4% in pre-market trading after Québecor Inc. proposed acquiring all outstanding shares at approximately CAD 19.45 per share, a 60% premium. Telus confirmed it will evaluate the offer, which includes cash and shares. The deal comes amid broader market declines and Telus's recent financial struggles, including a Q3 net loss.
Telus Corp. (T-T) has withdrawn from two planned AI data centres in Vancouver due to local opposition and strategic shifts. The company had planned to equip the centres with 63,000 Nvidia (NVDA-Q) chips and draw 163 megawatts of electricity. Westbank Corp. will continue the projects with a new partner. Telus remains open to future opportunities at these sites and will expand its facility in Kamloops, B.C.
Scotiabank kept TELUS at Sector Perform but raised its price target to $16.25 from $15.25, a 6.6% increase. The new target suggests a 26.9% upside from the Nov 6 close of $12.81. Recent analyst notes on TELUS have price targets ranging from $21 to $31.
Telus Corp reported Q3 results: service revenue down 1%, adjusted EBITDA down 5%, free cash flow down 35%, and adjusted EPS at CAD 0.16. The company plans CAD 900M annual savings by 2028, with 80% from telecom. It is in early talks to unlock value from its PureFibre network, retaining control.
The TSX gained 183.82 points to close at 35,789.09 on Friday, with gold and materials sectors leading gains. Allied Gold and Lundin Mining rose 6.8% and 5.5% respectively. The Canadian dollar fell 0.54 cents. U.S. markets saw mixed results, with the NASDAQ rebounding 1.1%.
Telus reported a C$660m net loss in Q3, with C$5bn revenue (down 1% YoY) and C$1.8bn EBITDA (down 5% YoY). The company plans C$900m annual savings by 2028, including an C$800m impairment charge for Telus Health. Vodafone Ireland will begin 5G standalone trials later this year. ETSI published a report on integrating computing with ISAC for 6G services.
TELUS CORP (TU) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 News Release Novem ber 6, 2026 TELUS Reports Third Quarter 2026 Results, Demonstrates Continued Discipline in Core Telecom; Advances Transformation Strategy Vancouver, B.C. – TELUS Corporation (TSX: T, NYSE: TU) today released its unaudited results for the third quar